Foot-and-Mouth Disease: all 46 studies
Page 1 of 1. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- Natural History of Trisomy 8-Associated Autoinflammatory Disease (TRIAD) and Related DisordersRecruitingNCT07683104
- Artificial Intelligence-driven Virtual Standardized Pediatric Patients TrialRecruitingNCT06699433Not applicable
- Surveillance of HFMD in Pediatric OutpatientsRecruitingNCT06263439
- Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years Old in IndonesiaNot yet recruitingNCT06251219
- Lot-to-lot Consistency Study of Three Commercial Batches of Enterovirus 71 VaccineRecruitingNCT06146088Phase 4
- Evaluation of Topical Rebamipide Versus Topical Betamethasone for Treatment of Oral Aphthous UlcersRecruitingNCT06084624Phase 2
- Sucralfate to Improve Oral Intake in Children With Infectious Oral Ulcers: a Randomized, Double-blind, Placebo-Controlled TrialCompletedNCT03241030Phase 2Results posted
- Apitoxin Versus Soft Laser for Management of Aphthous Ulceration.CompletedNCT07135609Not applicable
- Propolis as a Treatment Option for Hand Foot and Mouth DiseaseCompletedNCT06455007Phase 2/3
- Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal VaccineActive, not recruitingNCT06209398Phase 4
- A Serosurvey Study of Hand, Foot, and Mouth Disease in IndonesiaCompletedNCT05637229
- Combination of Diclofenac Potassium and Propolis in the Therapy of Oral AphthosisCompletedNCT05413096Early Phase 1
- Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in ShanghaiStatus unknownNCT05166044
- A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and ChildrenCompletedNCT05099029Phase 3
- Safety and Immunogenicity of High-dose IN-B001 in Healthy SubjectsStatus unknownNCT04637919Phase 1
- Safety & Immunogenicity of Enterovirus Type 71 Vaccine in Healthy Adults and Children 6-71monthsCompletedNCT04467541Phase 1/2
- Safety and Immunogenicity of CJ-40010 in Healthy SubjectsStatus unknownNCT04182932Phase 1
- Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization VaccinesCompletedNCT04111432Phase 4
- Clinical Trial of Enterovirus 71（EV71） Inactivated Vaccine in Children Aged 36-71 MonthsCompletedNCT03909074Phase 3
- Efficacy Trial of a Commercial EV71 VaccineCompletedNCT03903926Phase 4
- Immunity and Safety of Inactivated Enterovirus 71 Vaccine Post-marketing Among Children Aged 6-35 Months in ChinaCompletedNCT03893747Phase 4
- Immunogenicity and Safety of Two Different Commercial EV71 VaccinesCompletedNCT03873740Phase 4
- Study to Evaluate the Tolerance and Pharmacokinetics of Suramin SodiumStatus unknownNCT03804749Phase 1
- Efficacy Evaluation for Inactivated Vaccine (Vero Cell) Against EV71CompletedNCT03582761Phase 4
- The Phase IVd of Inactivated Enterovirus 71 VaccineStatus unknownNCT03296410Phase 4
- Five-year Immune Persistence Study of Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT03281174
- Phase IV Clinical Trial, Immunogenicity and Safety of EV71 VaccineCompletedNCT03278132Phase 4
- Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With EPI VaccinesCompletedNCT03274102Phase 4
- The Phase IVc of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell)Status unknownNCT03240744Phase 4
- The Phase IVb of Inactivated Enterovirus 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese ChildrenCompletedNCT03001986Phase 4
- Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 MonthsStatus unknownNCT02889497Phase 4
- Effect of Xiaoer Jiebiao Oral Liquid on Hand-foot-mouth DiseaseCompletedNCT02328651Phase 4
- Neurodevelopment Outcomes Following Severe Hand Foot and Mouth Disease in VietnamCompletedNCT02066714
- Magnesium Sulphate for Severe Hand, Foot and Mouth Disease in VietnamCompletedNCT01940250Phase 2
- Chinese Medicinal Treatment on Mild Hand, Foot, and Mouth Disease: Multicenter, Prospective, Randomized Double-blind, Placebo-controlled StudyCompletedNCT01769794Not applicable
- Immunogenicity and Safety of Three Consecutive Lots of a New Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01636245Phase 3
- A Phase II, Safety and Efficacy Study of Inactivated EV 71 Vaccine (Human Diploid Cell, KMB-17) in Chinese InfantsCompletedNCT01512706Phase 2
- A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 MonthsCompletedNCT01508247Phase 3
- An Efficacy Trial in Inactivated Enterovirus Type 71 (EV71) VaccineCompletedNCT01507857Phase 3
- A Safety Study of Inactivated EV71 Vaccine (Human Diploid Cell, KMB-17) in Chinese Adults, Children and InfantsCompletedNCT01391494Phase 1
- Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71CompletedNCT01376479Phase 1
- A Clinical Trial for Inactivated Vaccine(Vero Cell) Against EV71 in Chinese Healthy Young Adults and ChildrenCompletedNCT01267903Phase 1
- Study on Dynamic Changes of the Maternal Anti-EV71 and Anti-CVA16 Antibody Levels in Infants and Young ChildrenCompletedNCT01255124
- A Clinical Trial to Evaluate the Effectiveness and Safety of Chinese Medicine in the Treatment of Mild Type of Hand, Foot, and Mouth DiseaseCompletedNCT01182532Not applicable
- A Clinical Trial to Evaluate the Effectiveness and Safety of Xiyanping Injection in the Treatment of Mild Type of Hand, Foot, and Mouth DiseaseStatus unknownNCT01182025Not applicable
- A Multi-Center Clinical Trial To Evaluate Chinese Herbal Medicines in the Treatment of Severe Hand-foot-mouth DiseaseStatus unknownNCT01145664Not applicable